2,5-Disubstituted pyridines: The discovery of a novel series of 5-HT2A ligands
摘要:
This report describes the effect of replacing the central basic amine present in many known 5-HT2A ligands with an aromatic residue. We targeted the isomeric phenethylpyridines 2 and 3 and these compounds proved to be excellent leads, possessing good 5-HT2A receptor binding affinity and selectivity over the 5-HT2C subtype. Optimization of one isomer led to the identification of 25, a compound with sub-nanomolar 5-HT2A affinity and selectivity over 5-HT2C of greater than 4600-fold. (c) 2007 Elsevier Ltd. All rights reserved.
2,5-Disubstituted pyridines: The discovery of a novel series of 5-HT2A ligands
摘要:
This report describes the effect of replacing the central basic amine present in many known 5-HT2A ligands with an aromatic residue. We targeted the isomeric phenethylpyridines 2 and 3 and these compounds proved to be excellent leads, possessing good 5-HT2A receptor binding affinity and selectivity over the 5-HT2C subtype. Optimization of one isomer led to the identification of 25, a compound with sub-nanomolar 5-HT2A affinity and selectivity over 5-HT2C of greater than 4600-fold. (c) 2007 Elsevier Ltd. All rights reserved.
[EN] DIARYLSULFONES AS 5-HT2A ANTAGONISTS<br/>[FR] DIARYLSULFONES EMPLOYÉES EN TANT QU'ANTAGONISTES DU RÉCEPTEUR 5-HT2A
申请人:MERCK SHARP & DOHME
公开号:WO2006021805A1
公开(公告)日:2006-03-02
Compounds of formula (I) are potent and selective antagonists of the human 5-HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
Compounds of formula I:
are potent and selective antagonists of the human 5-HT
2A
receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
Compounds of formula I:
are potent and selective antagonists of the human 5-HT
2A
receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.